Anti-thrombotic activity of RG13965, a novel platelet fibrinogen receptor antagonist

Author： Bostwick J.S. Kasiewski C.J. Chu V. Klein S.I. Sabatino R.D. Perrone M.H. Dunwiddie C.T. Cook J.J. Leadley R.J.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.82, Iss.6, 1996-06, pp. : 495-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIb/IIIa antagonist

By Aoki T. Cox D. Senzaki K. Seki J. Tanaka A. Takasugi H. Motoyama Y.

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 439-450

Elsevier

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A. Mu D.-X. Hussain M.A.

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Identification of the active region responsible for the anti-thrombotic activity of anopheline anti-platelet protein from a malaria vector mosquito

By Hayashi Hideki

Platelets, Vol. 24, Iss. 4, 2013-06 ,pp. : 324-332

Informa Healthcare

Access to resources Recommend Favorite

Prasugrel, a Platelet P2Y₁₂ Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiplatelet and Antithrombotic Activity of RWJ-53308, A Novel Orally Active Glycoprotein IIb/IIIa Antagonist

By Damiano B.P. Mitchell J.A. Giardino E. Corcoran T. Haertlein B.J. de Garavilla L. Kauffman J.A. Hoekstra

Thrombosis Research, Vol. 104, Iss. 2, 2001-10 ,pp. : 113-126

Elsevier

Access to resources Recommend Favorite